Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Bolt Medical Inc. manages a company patent portfolio within the Medical Devices & Mechanical Engineering technology area. The company currently has 5 pending office actions. These actions are distributed across 5 distinct examiners, which indicates that each pending matter is being reviewed by a different individual at the patent office. This distribution suggests that no single examiner holds a majority of the current workload for the firm.
The portfolio spans 4 distinct art units. This variety in art units reflects the multidisciplinary nature of the mechanical and medical device technologies involved in the company's intellectual property. SHREYA PARAG ANJARIA is identified as the busiest examiner for this portfolio, currently handling 1 busiest examiner pending office action. This level of distribution across 4 art units requires the prosecution team to monitor multiple specialized groups simultaneously.
Practitioners should note that with 5 pending office actions across 5 distinct examiners, the prosecution strategy is highly decentralized. The fact that the busiest examiner only manages 1 pending action highlights a spread-out examination process. This structure ensures that the progress of the overall portfolio is not dependent on the timeline of a single examiner or a single art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ANJARIA, SHREYA PARAG | 1 | 53.7% | +26.8% |
| GUERRERO ROSARIO, ANA VERUSKA | 1 | 45.8% | +49.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18774528 | MULTIPLEXER FOR LASER-DRIVEN LITHOTRIPSY DEVICE | ANJARIA, SHREYA PARAG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18774528 | MULTIPLEXER FOR LASER-DRIVEN LITHOTRIPSY DEVICE | ANJARIA, SHREYA PARAG | — |
| 18357947 | ROUTING ASSEMBLY FOR INTRAVASCULAR LITHOTRIPSY CATHETER SYSTEM | GUERRERO ROSARIO, ANA VERUSKA | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18774528 | MULTIPLEXER FOR LASER-DRIVEN LITHOTRIPSY DEVICE | ANJARIA, SHREYA PARAG | 3796 | §102§103 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 18357947 | ROUTING ASSEMBLY FOR INTRAVASCULAR LITHOTRIPSY CATHETER SYSTEM | GUERRERO ROSARIO, ANA VERUSKA | 3794 | §102 | Non-Final OA | — | Pending | Jul 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial